Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. V. Further biological properties of the active substance
- PMID: 787603
- DOI: 10.1111/j.1348-0421.1976.tb00972.x
Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. V. Further biological properties of the active substance
Abstract
The neutral fraction (neutral CPS-K) of Klebsiella pneumoniae capsular polysaccharide (CPS-K) from type 1, Kasuya strain, has already been reported as the active substance responsible for the strong adjuvant effect of CPS-K. The present results demonstrate that neutral CPS-K exhibits further common biological activities with lipopolysaccharide (LPS) isolated from Salmonella enteritidis. The intensity of the lethality in mice of neutral CPS-K by the intraperitoneal route is very similar to that of LPS. Its lethality for mice by the intravenous (i.v.) route is significantly stronger than that of LPS, because the degree of increase in the sensitivity to their lethality by i.v. challenge is smaller for LPS than for neutral CPS-K. The intensity of the pyrogenicity of neutral CPS-K in rabbits is approximately one-tenth of that of LPS as judged by the minimal pyrogenic doses and fever indices. The skin-preparatory potency of neutral CPS-K for the dermal Shwartzman phenomenon in rabbits is also approximately one-tenth of that of LPS compared on the basis of the minimal skin-preparatory doses. When injected i.v., neutral CPS-K exhibits a provocative effect on hemorrhagic reactions in skin sites prepared with neutral CPS-K or LPS.
Similar articles
-
Effect of capsular polysaccharide of Klebsiella pneumoniae on host resistance to bacterial infections. I. Induction of increased susceptibility to infections in mice.Jpn J Microbiol. 1976 Jun;20(3):163-72. doi: 10.1111/j.1348-0421.1976.tb00971.x. Jpn J Microbiol. 1976. PMID: 9528
-
Interferon production in mice by the capsular polysaccharide of Klebsiella pneumoniae.Infect Immun. 1975 Jul;12(1):1-6. doi: 10.1128/iai.12.1.1-6.1975. Infect Immun. 1975. PMID: 166921 Free PMC article.
-
Interferon and cytotoxic factor (cytotoxin) released in the blood of mice infected with Mycobacterium bovis BCG. II. Influence of time after BCG inoculation on production of interferon and cytotoxin by capsular polysaccharide of Klebsiella pneumoniae or by bacterial lipopolysaccharide and on hyperreactivity to their lethal effects.Microbiol Immunol. 1979;23(5):395-402. doi: 10.1111/j.1348-0421.1979.tb00476.x. Microbiol Immunol. 1979. PMID: 388156
-
Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. VIII. Its effect on the size and the number of cells of regional lymph node and other lymphoid organs.Microbiol Immunol. 1980;24(2):141-54. doi: 10.1111/j.1348-0421.1980.tb00572.x. Microbiol Immunol. 1980. PMID: 6991886
-
Interferon and cytotoxic factor (cytotoxin) released in the blood of mice infected with Mycobacterium bovis BCG. I. Enhanced production of interferon and appearance of cytotoxin stimulated by capsular polysaccharide of Klebsiella pneumoniae or bacterial lipopolysaccharide.Microbiol Immunol. 1979;23(5):383-94. doi: 10.1111/j.1348-0421.1979.tb00475.x. Microbiol Immunol. 1979. PMID: 41163
Cited by
-
Crystallization of R-form lipopolysaccharides from Salmonella minnesota and Escherichia coli.J Bacteriol. 1990 Mar;172(3):1516-28. doi: 10.1128/jb.172.3.1516-1528.1990. J Bacteriol. 1990. PMID: 2407725 Free PMC article.
-
Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans.Infect Immun. 1978 Jun;20(3):760-9. doi: 10.1128/iai.20.3.760-769.1978. Infect Immun. 1978. PMID: 27461 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources